Gait disorders in patients with fibromyalgia - 06/12/06
, Richard Bileckot a, Anne-Sophie Alix b, Denis Chaleil c, Eric Barrey d
Corresponding author. Service de rhumatologie et médecine du Sport, centre hospitalier, 53000 Laval, France. Tel.: +33 2 43 66 50 00x7591; fax: +33 2 43 66 55 36.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 4 |
| Iconographies | 1 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Objectives |
The objective of this study was to compare gait in patients with fibromyalgia and in matched controls.
Methods |
Measurements must be obtained in patients with fibromyalgia, as the evaluation scales for this disorder are semi-quantitative. We used a patented gait analysis system (LocometrixTM Centaure Metrix, France) developed by the French National Institute for Agricultural Research. Relaxed walking was evaluated in 14 women (mean age 50±5 years; mean height 162±5 cm; and mean body weight 68±13 kg) meeting American College of Rheumatology criteria for fibromyalgia and in 14 controls matched on sex, age, height, and body weight.
Results |
Gait during stable walking was severely altered in the patients. Walking speed was significantly diminished (P<0.001) as a result of reductions in stride length (P<0.001) and cycle frequency (P<0.001). The resulting bradykinesia (P<0.001) was the best factor for separating the two groups. Regularity was affected in the patients (P<0.01); this variable is interesting because it is independent of age and sex in healthy, active adults.
Conclusion |
Measuring the variables that characterize relaxed walking provides useful quantitative data in patients with fibromyalgia.
Le texte complet de cet article est disponible en PDF.Keywords : Fibromyalgia, Accelerometry, Walking
Plan
Vol 73 - N° 5
P. 543-546 - octobre 2006 Retour au numéro
Article précédent
- Prevalence and risk factors of disk-related sciatica in an urban population in Tunisia
- Mohamed Younes, Ismail Béjia, Zouhour Aguir, Mondher Letaief, Saoussen Hassen-Zrour, Mongi Touzi, Naceur Bergaoui
- TNFα antagonist therapy in ankylosing spondylitis and psoriatic arthritis: recommendations of the French Society for Rheumatology
- Thao Pham, Francis Guillemin, Pascal Claudepierre, Mathieu Luc, Corinne Miceli-Richard, Bruno Fautrel, Michel de Bandt, Maxime Breban, Philippe Goupille, Jean-Francis Maillefert, Charles Masson, Alain Saraux, Thierry Schaeverbeke, Daniel Wendling, Xavier Mariette, Bernard Combe
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?